Search results for "salvage"

showing 10 items of 126 documents

Diagnosis of silent coronary ischemia with selective coronary revascularization might improve 2-year survival of patients with critical limb-threaten…

2021

Abstract Background Patients with critical limb-threatening ischemia (CLTI) have had poor long-term survival after lower extremity revascularization owing to coexistent coronary artery disease. A new cardiac diagnostic test, coronary computed tomography-derived fractional flow reserve (FFRCT), can identify patients with ischemia-producing coronary stenosis who might benefit from coronary revascularization. We sought to determine whether the diagnosis of silent coronary ischemia before limb salvage surgery with selective postoperative coronary revascularization can reduce the incidence of adverse cardiac events and improve the survival of patients with CLTI compared with standard care. Metho…

Malemedicine.medical_specialtyTime FactorsComputed Tomography AngiographyCritical IllnessIschemiaFractional flow reserveCoronary Artery Disease030204 cardiovascular system & hematologyCoronary AngiographyRisk AssessmentCoronary artery disease03 medical and health sciencesPeripheral Arterial Disease0302 clinical medicineIschemiaPredictive Value of TestsRisk FactorsInternal medicinemedicineMyocardial RevascularizationHumans030212 general & internal medicineMyocardial infarctionProspective StudiesStrokeAgedbusiness.industryHazard ratioCoronary ischemiaMiddle Agedmedicine.diseaseLimb SalvageFractional Flow Reserve MyocardialStenosisTreatment OutcomeCase-Control StudiesAsymptomatic DiseasesCardiologySurgeryFemaleCardiology and Cardiovascular MedicinebusinessJournal of vascular surgery
researchProduct

Value of the deep femoral artery as alternative inflow source in infrainguinal bypass surgery.

2013

Background The purpose of this study was to analyze the long-term results of infrainguinal bypass surgery using the deep femoral artery (DFA) as the inflow source. Methods Between 1998 and 2011, 88 bypasses of the lower limb were placed in 86 patients (mean age 71 years) using the deep femoral artery as inflow. Patients' records were retrieved from a computerized database and analyzed retrospectively. Results Critical limb ischemia (rest pain/tissue loss) was the indication in the majority (87.5%) of cases. The distal anastomosis of the bypass grafts was located at the popliteal level in 32 cases and the tibial (pedal) level in 52 cases, respectively, with the autologous vein as conduit in …

Malemedicine.medical_specialtyTime FactorsInfrainguinal bypassCritical IllnessInflowFemoral arteryKaplan-Meier EstimateIschemiamedicine.arterymedicineDeep Femoral ArteryHumansVascular PatencyAgedRetrospective StudiesAged 80 and overPeripheral Vascular DiseasesGroinbusiness.industryGeneral MedicineCritical limb ischemiaPerioperativeMiddle Agedmedicine.diseaseLimb SalvageSurgeryFemoral Arterymedicine.anatomical_structureTreatment OutcomeLower ExtremitySurgeryVascular GraftingRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessCalcificationAnnals of vascular surgery
researchProduct

Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).

2007

Objective Femoropopliteal bypass still is the standard surgical therapy for disabling claudication and critical ischemia. When autologous vein is not suitable synthetic or biological prostheses may be considered. Second generation glutaraldehyde tanned human umbilical vein (HUV) graft was chosen for above and below knee femoropopliteal bypass when autologous vein was not available. A single center experience regarding long-term graft function, secondary reinterventions, and potential biodegeneration of the HUV is presented. Methods Between January 1994 and January 2005, 211 consecutive femoropopliteal bypass operations with HUV (65 above knee and 146 below knee) were performed in 197 patien…

Malemedicine.medical_specialtyUmbilical VeinsTime FactorsTissue FixationAnastomosisProsthesis DesignSeverity of Illness IndexBlood Vessel Prosthesis ImplantationFixativesAneurysmIschemiamedicineHumansPopliteal ArteryDerivationVeinVascular PatencyAgedRetrospective StudiesUltrasonographyAged 80 and overBioprosthesismedicine.diagnostic_testbusiness.industryGreat saphenous veinGraft Occlusion VascularThrombosisIntermittent ClaudicationMiddle Agedmedicine.diseaseLimb SalvageThrombosisSurgeryBlood Vessel ProsthesisFemoral Arterymedicine.anatomical_structureTreatment OutcomeLower ExtremityGlutaralAngiographySurgeryFemaleRadiologymedicine.symptombusinessClaudicationCardiology and Cardiovascular MedicineFollow-Up StudiesJournal of vascular surgery
researchProduct

Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant …

2011

Objective To investigate the activity and toxicity of metronomic chemotherapy with low-dose oral cyclophosphamide (CTX) and methotrexate (MTX) in patients with metastatic CRPC that progresses after docetaxel. Patients with castration-resistant prostate cancer (CRPC) that progresses after docetaxel may benefit from receiving further chemotherapy. Methods Patients were treated with CTX 50 mg/d p.o. plus MTX 2.4 mg p.o. twice per week without rest periods. All patients received simultaneous luteinizing hormone-releasing hormone analogue. Prostate-specific antigen (PSA) response was defined as a 50% reduction on 2 evaluations at least 4 weeks apart. Objective response was measured according to …

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentSalvage therapyPhases of clinical researchAdministration OralAntineoplastic AgentsDocetaxelAdenocarcinomaGastroenterologyCyclophosphamide docetaxel methotrexate metronomic chemotherapy prostate carcinomaSettore MED/24 - UrologiaProstate cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansTreatment FailureCyclophosphamideSalvage TherapyChemotherapyLeukopeniabusiness.industryProstatic Neoplasmsmedicine.diseaseMetronomic ChemotherapySurgeryMethotrexateDocetaxelTolerabilityAdministration MetronomicTaxoidsmedicine.symptombusinessmedicine.drug
researchProduct

Surgical conversion with graft salvage as a definitive treatment for persistent type II endoleak causing sacenlargement

2015

Objective The goal of this study was to present open surgical conversion with graft salvage or "semiconversion" as a definitive and safe treatment for untreatable and persistent type II endoleaks causing sac enlargement after endovascular aneurysm repair. Methods Between January 2001 and December 2014, 25 of 1623 endovascular aortic repair (EVAR) patients were selected as candidates for open semiconversion. The indication was persistent type II endoleak in 13 patients (12 of whom received previous attempts of embolization), type I and II endoleak in 2 patients, and sac growth without imaging evidence of endoleak in the other 10. After the infrarenal aorta was prepared (via a retroperitoneal…

Malemedicine.medical_specialtygraft salvageEndoleakmedicine.medical_treatmentSurgical conversionEndovascular aneurysm repairSettore MED/22 - Chirurgia VascolareBlood Vessel Prosthesis ImplantationAneurysmmedicineHumansEffective treatmentEmbolizationThrombusbusiness.industryMedicine (all)Patient SelectionEndovascular ProceduresPerioperativeCardiology and Cardiovascular Medicine; Surgerymedicine.diseaseConversion to Open SurgerySize increaseSurgeryEmergency conditionFemaleSurgerySurgical conversion; graft salvage; type II endoleakRadiologytype II endoleakCardiology and Cardiovascular MedicinebusinessConversion to Open Surgery; Endoleak; Endovascular Procedures; Female; Humans; Male; Patient Selection; Blood Vessel Prosthesis Implantation; Cardiology and Cardiovascular Medicine; Surgery; Medicine (all)
researchProduct

Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature.

2014

The intrinsic physical and radiobiological characteristics of High Dose Rate Brachytherapy (HDR-BT) are well suited to the treatment of prostate cancer. HDR-BT was initially used as a boost to external beam brachytherapy, but has subsequently been employed as the sole treatment, which is termed HDR monotherapy. This review summarizes the clinical outcomes and toxicity results of the principal studies and discusses the radiobiological basis supporting its use.

Malemedicine.medical_specialtymedicine.medical_treatmentBrachytherapyBrachytherapyProstate cancermedicineEffective treatmentHumansMedical physicsDose FractionationSalvage brachytherapySalvage TherapyProstate cancerbusiness.industryRadiobiologyProstatic NeoplasmsRadiotherapy DosageHDR-BTHematologymedicine.diseaseBrachytherapy boost; HDR-BT; High-dose rate brachytherapy; Prostate cancer; Radiobiology; Salvage brachytherapy; Dose Fractionation; Humans; Male; Prostatic Neoplasms; Salvage Therapy; Treatment Outcome; Brachytherapy; Radiotherapy Dosage; Hematology; Oncology; Geriatrics and GerontologyHigh-Dose Rate BrachytherapyBrachytherapy boostTreatment OutcomeOncologyRadiologyDose Fractionation RadiationGeriatrics and GerontologybusinessHigh-dose rate brachytherapySalvage brachytherapyCritical reviews in oncology/hematology
researchProduct

Posterior compartment of the lower leg reconstruction with free functional rectus femoris transfer after sarcoma resection.

2009

A 72-year-old man with the third recurrence of a low-grade liposarcoma of the right lower leg came to our attention seeking limb-salvage surgery. The tumour was removed en bloc with all the superficial posterior compartment of the leg. Appropriate foot flexion was restored by means of a free-functional rectus femoris musculocutaneous flap harvested from the ipsilateral thigh. The patient was kept on a postoperative splint for 6 weeks. Three months after the operation, clinical and elecromyographic signs of reinnervation were observed. The patient was able to walk, run and climb stairs and no donor-site morbidity was observed. Thigh extension was rated M4, comparable to the contralateral thi…

Malemedicine.medical_specialtymedicine.medical_treatmentPosterior compartment of the lower leg reconstruction with free functional rectus femoris transfer after sarcoma resection.LiposarcomaThighSurgical FlapsQuadriceps MuscleMedicineHumansSurgical FlapsCompartment (pharmacokinetics)Anterior compartment of thighAgedLegMuscle Neoplasmsbusiness.industryAnatomyLiposarcomaPlastic Surgery Proceduresmedicine.diseaseLimb SalvageSurgerybody regionsmedicine.anatomical_structureSurgerySarcomaNeoplasm Recurrence LocalbusinessSplint (medicine)ReinnervationJournal of plastic, reconstructiveaesthetic surgery : JPRAS
researchProduct

Early post-fire bird community in European boreal forest: Comparing salvage-logged with non-intervention areas

2019

Salvage logging after disturbances in forests substantially modifies vegetation structureand dead wood availability, but empirical evidence on its impact on biodiversity, especiallyin European boreal forest, is sparse. In this study we investigated the short-term effect ofpost-fire salvage logging on species richness and abundance of birds in recently burnedmixed coniferous forest. Using point counts we estimated local species composition at 49salvaged sites and 55 non-intervention sites (burnt forest left for natural regeneration) thatwere not logged after afire in south-central Sweden. Local species richness, abundanceand Simpson's species diversity index were significantly higher at non-…

Natural disturbanceForest managementBird communitiesForest fireSalvage loggingBoreal forestGlobal Ecology and Conservation
researchProduct

Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients.

2021

We have analyzed treatment patterns and outcomes of relapsed/refractory(R/R) FLT3mut AML adult patients registered in our institutional data base between 1998 and 2018. Overall, 147 patients were evaluable: 34 from 1998 to 2009, 113 from 2010 to 2018. Salvage treatments were intensive chemotherapy ( n = 25, 74%), and supportive care ( n = 9, 26%) in the 1998-2009 period, and intensive chemotherapy ( n = 63, 56%), hypomethylating agent ( n = 7, 6%), low-dose cytarabine-based ( n = 8, 7%), clinical trial ( n = 16, 14%) and supportive care ( n = 19, 17%) in the 2010-2018 period. Complete remission (CR) or with incomplete recovery (CRi) rate was 44%, 49% among patients treated intensively (vs 3…

OncologyAdultCancer Researchmedicine.medical_specialtyreal-world*real-world03 medical and health sciences0302 clinical medicineRefractoryInternal medicineAntineoplastic Combined Chemotherapy Protocolsmedicine*FLT3mut AMLHumansPatterns of carerelapseSalvage TherapyAdult patientsFLT3mut AMLbusiness.industryFLT3mut AML real-world relapse/refractoryRemission InductionCytarabineMyeloid leukemiaHematology*relapse/refractoryrefractoryLeukemia Myeloid AcuteTreatment OutcomeOncologyfms-Like Tyrosine Kinase 3030220 oncology & carcinogenesisRelapsed refractorybusiness030215 immunologyLeukemialymphoma
researchProduct

Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia

2017

Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia

OncologyAdultMaleCancer Researchmedicine.medical_specialtyMyeloidAdolescentmedicine.medical_treatmentSalvage therapyHematopoietic stem cell transplantationOutcome (game theory)03 medical and health sciencesYoung Adult0302 clinical medicineText miningRecurrencehemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansYoung adultLetter to the EditorAgedAged 80 and overSalvage Therapybusiness.industryHematopoietic Stem Cell TransplantationMyeloid leukemiaHematologyMiddle Agedmedicine.diseasePrognosisLeukemiaLeukemia Myeloid Acutemedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisFemalebusiness030215 immunologyLeukemia
researchProduct